TK
Elite
in Pantothenate Kinase-Associated Neurodegeneration
About Thomas Klopstock

Thomas Klopstock is in Munich, Germany. Klopstock is rated as an Elite expert by MediFind in the treatment of Pantothenate Kinase-Associated Neurodegeneration. He is also highly rated in 34 other conditions, according to our data. His top areas of expertise are Leber Hereditary Optic Neuropathy, Optic Nerve Atrophy, Pantothenate Kinase-Associated Neurodegeneration, and Hallervorden-Spatz Disease.

His clinical research consists of co-authoring 231 peer reviewed articles and participating in 8 clinical trials in the past 15 years. In particular, he has co-authored 11 articles and participated in 3 clinical trials in the study of Pantothenate Kinase-Associated Neurodegeneration.

Locations
  Munich, BY 81675, DE
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials



Recruiting
Enrollment Status:Recruiting
Intervention Type:Diagnostic Test, Other
Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders
View Trial






View 5 Less Clinical Trials -

231 Total Publications

Journal: International ophthalmology clinics
Published —September 29, 2021
Gene Therapies for the Treatment of Leber Hereditary Optic Neuropathy.


Save this expert for later
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more